Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Htic, Inc

Clinical trials sponsored by Htic, Inc, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New antibody HT31-1 enters human trials for ARDS Results expected Jan 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

New antibody HT31-1 enters human trials for ARDS

Disease control Recruiting now

This early-stage trial tests a new antibody called HT31-1 in 24 healthy volunteers to see if it is safe and how the body processes it. The antibody targets a protein linked to inflammation in acute respiratory distress syndrome (ARDS), a severe lung condition often caused by infe…

Phase 1 • Sponsor: HTIC, Inc • Aim: Disease control

Last updated Sep 18, 2026 00:00 UTC